1. Australia Stocks

  2. •

    Distribution services

  3. •

    Medical distributors
Paragon Care Limited

Paragon Care Limited

AASX:PGC
0.15
AUD
0.00
(0.00%)
0.01EPS
49.10P/E
728.33MMarket Cap
Mar 04Next Earn
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
Revenue per Share
0.46
0.37
0.33
0.46
0.68
0.71
0.67
1.11
0.69
0.7
0.55
0.47
3.18
Basic EPS, GAAP
- -
0.02
0.02
0.03
0.06
0.06
0.05
-0.06
-0.23
0.02
0.01
0.02
0.01
Free Cash Flow per Basic Share
-0.02
0.01
-0.04
-0.01
0.04
0.04
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
0.01
0.01
0.01
0.02
0.02
0.05
- -
- -
- -
0.01
0.01
Book Value per Share
0.19
0.23
0.26
0.29
0.45
0.5
0.6
0.57
0.33
0.36
0.37
0.37
0.18
Tangible Book Value per Share
-0.06
0.04
0.07
0.02
-0.05
-0.09
-0.07
-0.04
-0.11
-0.09
-0.01
-0.02
-0.23
Basic Weighted Avg Shares
34
46
59
70
137
166
203
320
338
338
454
655
935
Sales/Revenue/Turnover
16
17
19
32
93
117
137
355
232
236
248
308
2,970
Operating Margin (%)
-0.93
5.52
6.18
9.34
11.24
12.36
6.29
7.48
0.89
7.4
7.55
7.83
0.96
Depreciation Expense
- -
- -
- -
- -
1
1
2
10
8
6
8
10
14
Net Income, GAAP
- -
1
1
2
8
10
11
-19
-77
8
7
11
8
Effective Tax Rate (%)
- -
- -
2.65
22.01
23.7
28.52
19.89
29.47
- -
32.86
33.16
24.93
40.36
Profit Margin (%)
-0.49
4.33
5.61
6.53
8.07
8.69
8.02
-5.22
-33.35
3.51
2.68
3.5
0.28
Working Capital
1
3
7
6
27
15
67
65
21
31
71
39
186
LT Debt
4
3
3
7
31
29
94
108
95
88
105
100
225
Total Equity
6
10
18
21
73
83
170
192
112
122
242
252
292
Return on Invested Capital (%)
- -
- -
6.35
8.37
11.05
8.93
3.47
6.36
- -
5.07
3.1
4.65
3.06
Return on Capital (%)
- -
- -
8.02
9.56
12.07
9.93
6.44
-4.12
- -
5.67
3.27
3.32
3.28
Return on Common Equity (%)
-1.35
8.8
7.59
10.84
16.13
13.09
8.66
-10.23
-50.74
7.08
3.71
4.49
3.14

Capital Structure

AUD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

AUD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

AUD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
48.48%
17.15%
15.74%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
35.16%
45.25%
-22.11%
Sales/Revenue/Turnover
132.02%
172.32%
865.41%
Total Cash Common Dividend
- -
- -
59.94%

Semi-annual Revenue

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2022
- -
- -
248
2023
- -
- -
308
2024
- -
- -
2,970

Semi-annual Earnings Per Share

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2022
- -
- -
0.01
2023
- -
- -
0.02
2024
- -
- -
0.01

Semi-annual Dividends Per Share

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2022
- -
- -
- -
2023
- -
- -
0.01
2024
- -
- -
0.01

Company Description

Company Profile APIChatGPT
CEO
Carmen Riley
Full Time Employees
1,619
Sector
Distribution services
Industry
Medical distributors
Address
77-97 Ricketts Road Mt. Waverley VIC Australia 3149
IPO Date
Oct 15, 1999
Website
paragoncare.com.au
Similar Companies
DataMeds AI, Inc. (NASDAQ:MEDS)
McKesson Corporation (NYSE:MCK)
Selcuk Ecza Deposu Ticaret ve Sanayi A.S. (BIST:SELEC)
Ibnsina Pharma (EGX:ISPH)
Cardinal Health, Inc. (NYSE:CAH)
Entero Healthcare Solutions Limited (NSE:ENTERO)
Business
Paragon Care Limited (ASX:PGC) is an Australia-based healthcare company that supplies medical equipment, devices, consumables, and related services to acute care, aged care, veterinary, and ancillary healthcare markets across Australia, New Zealand, and Asia. The company operates through four specialty pillars, including Capital & Consumables encompassing durable medical equipment, pharmaceuticals, nutritional products, over-the-counter items, and medical supplies; Specialty Diagnostics featuring reagent red blood cells, monoclonal blood grouping reagents, ancillary immunohematology products, and laboratory equipment; Specialty Devices covering eye care solutions for optometry and ophthalmic surgery, orthopaedic prosthetics for hips and knees, pain management systems, robotics, dental services, and aesthetics products; and Service & Technology providing equipment maintenance, repairs, preventative programs, technical support, and lifecycle management via a network of over 50 engineers. Founded in 1994 and headquartered in South Melbourne, Victoria, Paragon Care serves healthcare providers, hospitals, laboratories, aged care facilities, and veterinary practices with a focus on advanced technology solutions driven by ageing populations and rising healthcare demands. In June 2024, Paragon Care completed a major merger with CH2 Holdings Pty Limited (also known as Clifford Hallam), integrating distribution of pharmaceuticals, medical consumables, and nutritional products to create a leading healthcare wholesaler and distributor with enhanced scale across Australia, New Zealand, and Asia. The company reported underlying revenue exceeding A$3.6 billion and EBITDA of A$95.2 million for the fiscal year ended June 30, 2025, with 20% revenue growth in Asia to A$101 million, alongside launches of new divisions in aesthetics, robotics, and dental services. In November 2025, Paragon Care agreed to acquire Haju Medical, an Indonesian aesthetics services provider, for A$70 million to expand its Asia-Pacific footprint, with completion expected by January 2026 subject to regulatory approvals; this follows strategic expansions supported by new working capital facilities in New Zealand and Thailand.

Company News

Company News APIChatGPT

  • defenseworld.net

    David Collins Buys 2,000,000 Shares of Paragon Care (ASX:PGC) Stock